By: IPP Bureau
Last updated : August 17, 2026 7:13 pm
With its term loan fully repaid, the company is entering its next phase with a focus on profitable growth, disciplined execution and long-term value creation across its healthcare businesses
API Holdings, India’s largest digital healthcare platform and the ultimate parent company of Thyrocare Technologies, has become debt-free after repaying its outstanding term debt of Rs. 1,050 crore. The repayment was funded through proceeds from the recent sale of part of its stake in Thyrocare and internal accruals.
The development follows the sale by Docon Technologies Private Limited, the promoter and holding company of Thyrocare, of 1,57,69,696 Thyrocare shares, representing approximately 9.90% of the company’s paid-up equity share capital, through market trades.
Following the transaction, Docon continues to remain the promoter and holding company of Thyrocare with a 51.02% stake. The repayment of the outstanding debt has also resulted in the release of the pledge on the remaining Thyrocare shares held by Docon, leaving its entire 51.02% holding fully unencumbered.
Alok Kumar Jagnani, Whole-Time Director and Group CFO, API Holdings, said the company had repaid its term debt in full without reducing its ownership in Thyrocare below 51%.
“We’ve repaid our term debt in full, and we did it the hard way, without diluting our stake in Thyrocare below 51%. That’s the real headline: a stronger balance sheet without giving up our ownership. It reflects a capital allocation philosophy where growth and discipline aren’t traded off against each other,” Jagnani said.
“With every business in the group soon profitable, there’s no drag left on the P&L; just a clean base to build from,” he added.
Siddharth Shah, Vice Chairman, API Holdings, said the acquisition of Thyrocare had delivered value for API shareholders.
“The Thyrocare acquisition has worked out well for API. Shareholders who held on instead of tendering to our open offer at Rs. 433 a share in July 2021 (bonus adjusted) are sitting on Rs. 653 at close of trading on 14th August 2026 — dividends included. That’s a 51% return. NIFTY 50 gave you 41%. Pathology peers weren’t even close,” Shah said.
Rahul Guha, MD & CEO, API Holdings and Thyrocare, said the company’s zero-debt position marks the beginning of its next phase rather than an endpoint.
“Zero debt isn’t the finish line; it’s the starting gun. This wasn’t financial engineering; it was Thyrocare’s and the group’s execution, quarter after quarter, that made it possible,” Guha said.